Hereditary Angioedema Exacerbated by Estrogen Supplementation Treatment for Uterine Fibroid — A Therapeutic Challenge

Hereditary Angioedema Exacerbated by Estrogen Supplementation Treatment for Uterine Fibroid — A Therapeutic Challenge

Authors

  • Alicja Mesjasz Department of Allergology, Faculty of Medicine, Medical University of Gdansk, Poland
  • Kinga Bojahr Department of Allergology, Faculty of Medicine, Medical University of Gdansk, Poland
  • Jan Romantowski Department of Allergology, Faculty of Medicine, Medical University of Gdansk, Poland
  • Marek Niedoszytko Department of Allergology, Faculty of Medicine, Medical University of Gdansk, Poland

Keywords:

hereditary angioedema, HAE, HAE type II

References

Kargarsharif F, Mehranmehr N, Zahedi Fard S, Fazlollahi MR. Type I and Type II Hereditary Angioedema: Clinical and Laboratory Findings in Iranian Patients . Arch Iran Med 2015;18:425–9.

Bernstein JA. Severity of hereditary angioedema, prevalence, and diagnostic considerations. Am J Manag Care 2018;24:S292–8.

Fijen LM, Bork K, Cohn DM. Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2. Clin Rev Allergy Immunol 2021;61:66–76. https://doi.org/10.1007/S12016-021-08832-X.

Downloads

Published

2024-04-30

How to Cite

1.
Mesjasz A, Bojahr K, Romantowski J, Niedoszytko M. Hereditary Angioedema Exacerbated by Estrogen Supplementation Treatment for Uterine Fibroid — A Therapeutic Challenge. Dermatol Pract Concept. 2024;14(2):e2024130. doi:10.5826/dpc.1402a130

Share